MetLife Investment Advisors »

Evommune shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $139k 6.0k 22.99

More positions owned by MetLife Investment Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A Cap Stk Cl (GOOGL)
Broadcom (AVGO)
Alphabet Inc Class C Cap Stk Cl (GOOG)
Meta Platforms Inc Class A Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Class B Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
State Street Spdr S&p Etf Trust Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Vanguard Short-term Bond Index Fun Short Trm (BSV)
Exxon Mobil Corporation (XOM)

View all positions for MetLife Investment Advisors

Top funds holding Evommune

EQT Fund Management S.a r.l.
RA Capital Management
Pivotal bioVenture Partners Investment Advisor
Andera Partners
Rtw Investments
MPM Oncology Impact Management
Nan Fung Group Holdings
SymBiosis Capital Partners
Eventide Asset Management
Henderson Group
Marshall Wace
Baker Bros. Advisors
Alyeska Investment Group
Defilade Capital Management
BlackRock

View all funds holding Evommune